Cocrystal Pharma
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $105 | $225 | $0 | $0 |
Gross Profit | 105 | 134 | 1,394 | -954 |
EBITDA | -3,140 | -2,208 | -2,335 | -1,810 |
EBIT | -3,164 | -2,299 | -2,426 | -2,049 |
Net Income | -3,164 | -2,299 | -2,426 | -2,049 |
Net Change In Cash | 105 | 225 | 0 | 0 |
Free Cash Flow | -2,516 | -2,340 | -1,736 | -1,561 |
Cash | 2,169 | 4,685 | 7,025 | 7,729 |
Basic Shares | 13,788 | 13,786 | 11,290 | 10,991 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -5,055 | -12,537 | -15,169 | -12,392 |
EBITDA | -8,455 | -17,378 | -20,970 | -17,952 |
EBIT | -8,831 | -17,504 | -21,159 | -18,137 |
Net Income | -8,831 | -17,504 | -17,984 | -38,837 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -8,204 | -16,493 | -14,784 | -21,509 |
Cash | 7,025 | 9,860 | 26,353 | 37,144 |
Basic Shares | 11,290 | 10,174 | 9,651 | 8,143 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.23 |
2026-03-31 | -$0.17 |
2025-12-31 | -$0.17 |
2025-09-30 | -$0.19 |